Hirsch I H, McCue P, Kulp-Hugues D, Sedor J, Flanigan M
Department of Urology and Pathology, Jefferson Medical College, Philadelphia, Pennsylvania.
J Urol. 1993 Aug;150(2 Pt 1):342-6. doi: 10.1016/s0022-5347(17)35480-0.
Objective determination of spermatogenesis has been accomplished by quantitative testicular biopsy, which, although laborious, has served as the standard for spermatogenic assessment. Aspiration deoxyribonucleic acid (DNA) flow cytometry of the testis, however, has simplified this determination, and has correlated with indirect hormonal parameters of spermatogenesis and qualitative observations of the seminiferous epithelium. Nevertheless, this important modality has yet to be validated against quantitative micrometry of the testis. To determine this correlation we submitted 29 incisional testicular biopsies for simultaneous quantitative analysis and DNA flow cytometry. Micrometric parameters included the mean tubular wall thickness, and the mean tubular concentration of late spermatids and Sertoli cells. The percentage of haploid, diploid and tetraploid cells was determined for each patient. For the entire patient population a statistically significant correlation was observed between the percentage of haploid cells and the tubular concentration of late spermatids (r = 0.784, p < 0.0005) as well as the mean tubular spermatid-to-Sertoli cell ratio (r = 0.824, p < 0.0005). A similar correlation was noted for various etiological subsets of patients: spinal cord injury (r = 0.809, p < 0.002), genital tract obstruction (r = 0.705, p < 0.02) and miscellaneous diagnoses (r = 0.828, p < 0.02). For the group with testicular failure quantitative micrometry and flow cytometry demonstrated severe impairment in all patients although a statistically significant correlation could not be shown because of the small range of values. DNA flow cytometry analysis correlates strongly with the current standard of quantitative spermatogenic assessment and, therefore, it may be validated as a simplified and highly objective method of determining spermatogenesis.
通过定量睾丸活检已实现对精子发生的客观测定,尽管该方法费力,但一直作为精子发生评估的标准。然而,睾丸抽吸脱氧核糖核酸(DNA)流式细胞术简化了这一测定过程,并且与精子发生的间接激素参数以及生精上皮的定性观察结果相关。尽管如此,这一重要方法尚未与睾丸定量显微测量法进行验证。为确定这种相关性,我们提交了29份切开睾丸活检样本进行同步定量分析和DNA流式细胞术检测。显微测量参数包括平均管壁厚度、晚期精子细胞和支持细胞的平均管腔浓度。测定了每位患者单倍体、二倍体和四倍体细胞的百分比。在整个患者群体中,观察到单倍体细胞百分比与晚期精子细胞的管腔浓度之间存在统计学显著相关性(r = 0.784,p < 0.0005),以及平均管腔精子细胞与支持细胞比例之间也存在相关性(r = 0.824,p < 0.0005)。在不同病因亚组的患者中也观察到类似的相关性:脊髓损伤(r = 0.809,p < 0.002)、生殖道梗阻(r = 0.705,p < 0.02)和其他诊断(r = 0.828,p < 0.02)。对于睾丸功能衰竭组,定量显微测量和流式细胞术显示所有患者均有严重损害,尽管由于值的范围较小无法显示统计学显著相关性。DNA流式细胞术分析与当前精子发生定量评估的标准密切相关,因此,它可被验证为一种简化且高度客观的确定精子发生的方法。